P.2.d.009 The predictive role of Val66Met polymorphism on levels of BDNF along treatment of medication-free patients with bipolar disorder

Iría Grande; Pedro Vieira da Silva Magalhães; Inês Chendo; L. Sterzt; GR Fries; KM Ceresér; Maurício Kunz; Benício N. Frey; Eduard Vieta; Flávio Kapczinski

doi:10.1016/s0924-977x(13)70580-7

Related publications

Article2013

P.2.d.028 Relating mood to plasma glutathione and BDNF levels in patients with bipolar disorder

Narinder Singh, Adriane Ribeiro Rosa, Wendy Whitaker, Marianne de Brito, Alexandra Lewis, Eduard Vieta, G.C. Churchull, John Geddes, G M Goodwin

Article2021

Effect of BDNF Val66Met polymorphism on hippocampal subfields in multiple sclerosis patients

Ermelinda De Meo, Emilio Portaccio, Elio Prestipino, Benedetta Nacmias, Silvia Bagnoli, Lorenzo Razzolini, Luisa Pastò, Claudia Niccolai, Benedetta Goretti, Angelo Bellinvia, Mattia Fonderico, Antonio Giorgio, Maria Laura Stromillo, Massimo Filippi, Sandro Sorbi, Nicola De Stefano, Maria Pia Amato

Article2009

P.2.e.009 Gynaecological and obstetric comorbidities in patients with bipolar disorder: a systematic review

Julio Bobes, J.M. Montes, José Luis Mostaza, Fernando Rico‐Villademoros, Eduard Vieta, Pilar A. Sáiz

Article2015

P.2.h.009 Maintenance of vortioxetine efficacy with long-term treatment of patients with major depressive disorder

Eduard Vieta, Henrik Loft, Ioana Florea

Article2013

Relating mood to plasma glutathione and BDNF levels in patients with bipolar disorder

Nivedita Singh, Adriane Ribeiro Rosa, Wayne L. Whitaker, Marianne de Brito, Alexandra Lewis, Eduard Vieta, G.C. Churchull, Geddes, Guy M. Goodwin